Insights into Company Bills & Payments

Axis Max Life Insurance ↗

📍 Gurugram, Haryana, India Active CIN U74899HR2000PLC143012 Insurance
Search companies

Key Metrics of Axis Max Life Insurance

Revenue—FY 2025-26
EBITDA—
Net profit₹277 Cr▼ 31.8% YoY
Net worth—
Competitors10identified

About Axis Max Life Insurance

Sectors

InsuranceLife Insurance

Company details

Website
axismaxlife.com
Registered office
Plot No. 90-c, Sector- 18,urban Estate,, Palam Road,, Gurugram, In-hr, 122015

Operational Areas of Axis Max Life Insurance

Insurance›Life Insurance

Company summary

Entity details

CINU74899HR2000PLC143012
LEI code335800PYI52N9U1N5X86
State codeHR
PIN code122015
Current legal nameAXIS MAX LIFE INSURANCE
Classification—
Listing statusUnlisted
Registration no.143012
Company age—
PAN—
CountryIndia
CityGurugram
StateHaryana
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueMGT-7 for FY 2025-26 · 29 Nov 2026

Industry classification

NIC code74899
Description of main activityOther business activities (consultancy, engineering, advertising, staffing)
Description of business activityOther business activities (consultancy, engineering, advertising, staffing)
SectorInsurance · Life Insurance
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date passed
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 23 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 11 Sep 2026 CARE AA+ Stable outlook · Reaffirmed
ICRA · 11 Sep 2026 ICRA AA+ Stable outlook · Reaffirmed
Change in last 12 monthsNo change
Change since first rating on recordNo changesince Feb 2025
Rating actions40 up · 0 down
Liquidity (CARE)Strong

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
11 Sep 2026ICRAReaffirmed AA+—Stable₹1,986 Cr View
11 Sep 2026CAREReaffirmed AA+—Stable₹1,986 Cr View
02 Feb 2026CAREReaffirmed AA+—Stable₹1,300 Cr View
03 Feb 2025CAREAssigned AA+——₹1,300 Cr View

Credit strengths (ICRA, Sep 2026)

+ Strong promoter profile

As on June 30, 2026, Axis, along with its subsidiaries, Axis Capital Limited and Axis Securities Limited, held an aggregate 19.99% stake in Axis Max Life, up from 19.02% as on March 31, 2026.

+ Established player in individual segment with balanced product mix

Axis Max Life is an established player in the life insurance industry, ranking among the top 4 private life insurers with a 7.5% market share in individual AFYP in FY2026.

+ Solvency supported by recent equity infusion

Axis Max Life’s solvency remained comfortable at 1.98 times as on June 30, 2026 (versus 1.94 times as on March 31, 2026 and 1.90 times as on March 31, 2024).

Credit challenges

− Operating expenses relatively higher than peers

Axis Max Life’s operating expenses (including commissions) remained higher than other larger private life insurance peers and increased further to25.4% of the gross written premium (GWP) in FY2026 from 20.8% in FY2023.

− Ability to maintain premium growth in individual segment

The regulatory landscape for the life insurance sector has changed significantly in recent years, with implications for growth and profitability.

Could lead to an upgrade

A material increase in the aggregate shareholding of Axis Bank and its subsidiaries in Axis Max Life beyond 19.99% and/or a sustained improvement in Axis Max Life’s market position and profitability will be

Could lead to a downgrade

A deterioration in the credit profile of Axis or a decline in the strategic importance of Axis Max Life to Axis or a dilution in the expectation of support from Axis would have a negative impact. Additionally, a sustained decline in the company’s solvency ratio to less than 1.70 times will be a negative factor.

Agency-reported financials (CARE, 11 Sep 2026)

MetricMarch 31, 2025March 31, 2026Q1FY27
Gross Direct Premium₹33,223 Cr₹38,877 Cr₹7,607 Cr
Profit after tax (PAT)₹406 Cr₹277 Cr₹78.00 Cr
Tangible net worth (TNW)*5,794.00×5,907.00×6,413.00×
Solvency (x)₹2.01 Cr₹1.94 Cr₹1.98 Cr
Persistency ratio (13th month) (%)85.0%83.0%83.0%
Persistency ratio (61st month) (%)53.0%58.0%59.0%

Borrowings & rated debt

Rated borrowing limits (latest)₹1,986 Cr
Peak rated limits₹1,986 CrSep 2026 · ICRA
Limits raised0 times2 new facilities rated
Weighted average coupon8.10%

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Action Subordinate debtSubordinated debt—₹686 Cr— AA+ (Stable)AssignedCARE
Subordinate debtSubordinated debt—₹1,300 Cr— AA+ (Stable)ReaffirmedCARE

Debt instruments

ISINInstrumentTypeCouponIssuedMaturityAmountRatingStatus
INE511N08024^^ FebSubordinated debt8.34% —— ₹500 CrAA+ Not stated
INE511N08032^^ SepSubordinated debt7.95% —— ₹800 CrAA+ Not stated
INE511N08016^ Aug *Subordinated debt7.50% —— ₹496 CrAA+ Withdrawn

CARE ratings on record (checked 26 Oct 2026)

InstrumentAmountRating
Subordinate Debt₹1,986 CrCARE AA+; Stable

Credit assessment · Life insurance

ICRA Rating Methodology – Life Insurance (Sep 2026) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityNot assessableAgency: Strong
DirectionRating watch – DevelopingAgency outlook: Stable
ICRA rating · Sep 2026AA+Matches indicative band

Ratios, pillar scores and the indicative rating are part of Premium.

Instrument ratings

InstrumentTypeRatedPer criteriaBasis
Action Subordinate debt Subordinated debtAA+ CARE AA+ senior − 0
Subordinate debt Subordinated debtAA+ CARE AA+ senior − 0
Complex Subordinated debtAA+ CARE AA+ senior − 0
Subordinated debt programme Subordinated debtAA+ ICRA AA+ senior − 0
Subordinated debt Subordinated debt Subordinated debtAA+ ICRA AA+ senior − 0
^^ Feb Subordinated debtAA+ ICRA AA+ senior − 0
^^ Sep Subordinated debtAA+ ICRA AA+ senior − 0
Subordinate Debt Subordinated debtAA+ CARE AA+ senior − 0
Feb Feb Subordinated debtAA+ CARE AA+ senior − 0
Sep Sep Subordinated debtAA+ CARE AA+ senior − 0
crore) Subordinate Debt Subordinated debtAA+ CARE AA+ senior − 0

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)72%
Information on file44% · missing: Liquidity position, Debt obligations and repayment schedule, Capex / investment plans, Auditor details, Shareholding pattern

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further funding possible with conditions Next rating action stable or better: 72% (Mostly stable) · ML model on 6893 rating histories, AUC 0.653
Rated limits₹1,986 Cr
Not yet allocated—
Extra debt within 3.5× EBITDA—
Interest coverage—
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 72% chance the next rating action is stable or better
  • Current rating AA+ (investment grade)

Rated limits by facility

Timeline

11 Sep 2026 CARE reaffirmed: AA+ (Stable)Rated limits ₹1,986 cr CARE rationale
11 Sep 2026 ₹1,612 cr raised through equity
From the report

ABL infused preferential equity capital of ₹1,612 crore in April 2024, and ₹381 crore through preferential issue in June 2026, increasing Axis Bank and its subsidiaries stake to 19.99% from 19.02%.

CARE rationale
11 Sep 2026 ₹381 cr raised from ABL
From the report

AMLI had an adequate solvency position as on June 30, 2026, with a solvency margin of 1.98x (as on March 31, 2026: 1.94x) supported by capital infusion of ₹381 crore by ABL in June 2026.

CARE rationale
11 Sep 2026 ICRA reaffirmed: AA+ (Stable)Rated limits ₹1,986 cr ICRA rationale
11 Sep 2026 ₹381 cr raised
From the report

The rating also considers the comfortable solvency position with a solvency ratio of 1.98 times as on June 30, 2026, following the growth capital infusion of around Rs. 381 crore in Q1 FY2027 and Rs. 1,612 crore in FY2025.

ICRA rationale
11 Sep 2026 ₹381 cr raised through equity
From the report

The increase followed the equity infusion of around Rs. 381 crore through a preferential allotment in June 2026, after the receipt of the requisite regulatory approval.

ICRA rationale
02 Feb 2026 CARE reaffirmed: AA+ (Stable)Rated limits ₹1,300 cr CARE rationale
02 Feb 2026 ₹1,612 cr raised through equity
From the report

ABL infused preferential equity capital of ₹1,612 crore in April 2024.

CARE rationale
02 Feb 2026 ₹1,612 cr raised from ABL
From the report

AMLI had an adequate solvency position as on September 30, 2025, with a solvency margin of 2.08x (as on March 31, 2025: 2.01x) supported by capital infusion of ₹1,612 crore by ABL in April 2024.

CARE rationale
03 Feb 2025 CARE assigned: AA+Rated limits ₹1,300 cr CARE rationale
03 Feb 2025 ₹1,612 cr raised through equity
From the report

ABL infused preferential equity capital of ₹1,612 crore in April 2024.

CARE rationale
03 Feb 2025 ₹1,612 cr raised from ABL
From the report

AMLI had an adequate solvency position as on September 30, 2024, with a solvency margin of 1.98 x (as on March 31, 2024: 1.72x) supported by capital infusion of ₹1,612 crore by ABL in April 2024.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officePLOT NO. 90-C, SECTOR- 18,URBAN ESTATE,, PALAM ROAD,, GURUGRAM, IN-HR, 122015
GSTIN—
Email—
Websitehttps://www.axismaxlife.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Axis Max Life Insurance

Competitors10identified
Locations2most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Life Insurance Corporation of India Outlets operated by LICI. licindia.in 1956 India
Sbi Life Insurance Company Limited Life Insurance · Community, personal and Social Services sbilife.co.in 2001 Mumbai, Maharashtra, India
HDFC Life Insurance Company Limited · Finance — — Mumbai, Maharashtra, India
Icici Prudential Life Insurance Company Limited Life Insurance · Insurance iciciprulife.com — Mumbai, Maharashtra, India
ICICI Life Insurance Limited Life Insurance · Insurance — — Mumbai, India
Canara Hsbc Life Insurance Company Limited Life Insurance · Insurance — — New Delhi, India
Kotak Life Insurance Life Insurance · Insurance insurance.kotak.com — Mumbai, India
Life Insurance Corporation of India (LIC) Life Insurance · Insurance licindia.in — India
SBI Life Insurance Part of SBI Holdings. sbilife.co.in 2001 Mumbai, India
ICICI Prudential Life Life Insurance · Insurance iciciprulife.com — Mumbai, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Life insurance

Filings

No filings on record yet.